Terms: = Cervical cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
94 results:
1. Dual T cell receptor/chimeric antigen receptor engineered NK-92 cells targeting the HPV16 E6 oncoprotein and the tumor-associated antigen L1CAM exhibit enhanced cytotoxicity and specificity against tumor cells.
Quiros-Fernandez I; Libório-Ramos S; Leifert L; Schönfelder B; Vlodavsky I; Cid-Arregui A
J Med Virol; 2024 May; 96(5):e29630. PubMed ID: 38659368
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
Kang SW; Kang OJ; Lee JY; Kim H; Jung H; Kim H; Lee SW; Kim YM; Choi EK
PLoS One; 2024; 19(2):e0298815. PubMed ID: 38363779
[TBL] [Abstract] [Full Text] [Related]
3. Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population.
Yao Y; Yan Z; Li C; Zhang S; Liu S; Zhang X; Shi L; Liu W; Shi L; Yao Y
HLA; 2024 Jan; 103(1):e15340. PubMed ID: 38212262
[TBL] [Abstract] [Full Text] [Related]
4. Ensuring equity in the era of HLA-restricted cancer therapeutics.
Smithy JW; Blouin A; Diamond LC; Postow M
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36442912
[TBL] [Abstract] [Full Text] [Related]
5. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against cervical cancer.
Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
[TBL] [Abstract] [Full Text] [Related]
6. Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in hla-a2 transgenic mice.
Peng S; Xing D; Ferrall L; Tsai YC; Hung CF; Wu TC
J Biomed Sci; 2022 Oct; 29(1):80. PubMed ID: 36224625
[TBL] [Abstract] [Full Text] [Related]
7. Association Between Human Leukocyte Antigen Polymorphism and Human Papillomavirus Infection in Brazilian Women.
de Araujo-Souza PS; El-Zein M; Bolpetti ADN; Maciag PC; Rabachini T; Franco EL; Villa LL
Sex Transm Dis; 2023 Jan; 50(1):50-58. PubMed ID: 36194829
[TBL] [Abstract] [Full Text] [Related]
8. Identification of human leukocyte antigen in precancerous and cancerous cervical lesions from Ecuadorian women.
Mora MJ; de Los Ángeles Bayas-Rea R; Mejía L; Cruz C; Guerra S; Calle P; Sandoval DM; Galarza JM; Zapata-Mena S
Infect Genet Evol; 2022 Nov; 105():105365. PubMed ID: 36108945
[TBL] [Abstract] [Full Text] [Related]
9. Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With cervical cancer.
Nosaka K; Suzuki S; Yoshikawa T; Shimomura M; Kitami K; Yoshida K; Yoshihara M; Kikkawa F; Nakatsura T; Kajiyama H
Anticancer Res; 2021 Oct; 41(10):4741-4751. PubMed ID: 34593423
[TBL] [Abstract] [Full Text] [Related]
10. Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2].
Takeuchi S; Kagabu M; Shoji T; Nitta Y; Sugiyama T; Sato J; Nakamura Y
Oncoimmunology; 2020 Nov; 9(1):1838189. PubMed ID: 33235818
[TBL] [Abstract] [Full Text] [Related]
11. Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix?
Kahn R; Zhou ZN; Goyal A; Gamble C; Nicholson N; Caputo TA; Holcomb K; Frey MK; Chapman-Davis E
Int J Gynecol Cancer; 2020 Sep; 30(9):1298-1302. PubMed ID: 32448806
[TBL] [Abstract] [Full Text] [Related]
12. Association of hla-a, -B, DRB, and DQB Alleles with Persistent HPV-16 Infection in Women from Tamil Nadu, India.
Bhaskaran M; Murali SV; Rajaram B; Krishnasamy S; Devasena CS; Pathak A; Ravi V; Swaminathan K; Ayyappa A; Vedhantham S; Seshachalam A; ArunKumar G
Viral Immunol; 2019 Dec; 32(10):430-441. PubMed ID: 31800372
[TBL] [Abstract] [Full Text] [Related]
13. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
[TBL] [Abstract] [Full Text] [Related]
14. A meta-analysis of association of Human Leukocyte Antigens A, B, C, DR and DQ with Human Papillomavirus 16 infection.
Bhaskaran M; ArunKumar G
Infect Genet Evol; 2019 Mar; 68():194-202. PubMed ID: 30590170
[TBL] [Abstract] [Full Text] [Related]
15. hla-a*30:01 and hla-a*33:03 are the protective alleles while hla-a*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China.
Alifu M; Hu YH; Dong T; Wang RZ
J Cancer Res Ther; 2018; 14(6):1266-1272. PubMed ID: 30488842
[TBL] [Abstract] [Full Text] [Related]
16. Engineered T cells targeting E7 mediate regression of human papillomavirus cancers in a murine model.
Jin BY; Campbell TE; Draper LM; Stevanović S; Weissbrich B; Yu Z; Restifo NP; Rosenberg SA; Trimble CL; Hinrichs CS
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669936
[TBL] [Abstract] [Full Text] [Related]
17. Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent cervical cancer.
Hasegawa K; Ikeda Y; Kunugi Y; Kurosaki A; Imai Y; Kohyama S; Nagao S; Kozawa E; Yoshida K; Tsunoda T; Nakamura Y; Fujiwara K
J Immunother; 2018 May; 41(4):201-207. PubMed ID: 29432282
[TBL] [Abstract] [Full Text] [Related]
18. Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in cervical cancer.
Bahls L; Yamakawa R; Zanão K; Alfieri D; Flauzino T; Delongui F; de Abreu A; Souza R; Gimenes F; Reiche E; Borelli S; Consolaro M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858203
[TBL] [Abstract] [Full Text] [Related]
19. Somatic Host Cell Alterations in HPV Carcinogenesis.
Litwin TR; Clarke MA; Dean M; Wentzensen N
Viruses; 2017 Aug; 9(8):. PubMed ID: 28771191
[TBL] [Abstract] [Full Text] [Related]
20. Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis.
Das Ghosh D; Mukhopadhyay I; Bhattacharya A; Roy Chowdhury R; Mandal NR; Roy S; Sengupta S
Int J Cancer; 2017 Jun; 140(11):2498-2508. PubMed ID: 28268260
[TBL] [Abstract] [Full Text] [Related]
[Next]
